Next-Generation Immunotherapies banner

The Next-Generation Immunotherapies conference will delve into the next frontier of immunotherapy development beyond Anti-PD-1/PD-L1 therapies. We invite speakers to examine strategies to target novel pathways, share updates on optimizing therapeutic window while minimizing toxicity for immunocytokines, multispecifics, and cell-based therapies. The debate between CARs and TILs will be highlighted, discussing off-the-shelf potential, toxicity management and improving persistence. Advances in engineered immune cells, cancer vaccines and the complexities of combination therapies will also be discussed. This conference aims to provide a forum for researchers to collaborate and discover the next breakthroughs in immunotherapy.

Recommended Short Course*
Monday, 4 November, 14:00 – 17:00
SC6: Introduction to Immunogenicity of Biotherapeutics
*Separate registration required. See short courses page for details. All short courses take place in-person only.






For more details on the conference, please contact:

Mimi Langley
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781-972-5439
Email: mlangley@healthtech.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com